BACKGROUND Otitis media with effusion is a common childhood disorder, which resolves on its own in a few months. Recurrence or persistence of the disease warrants treatment with medical or surgical intervention according to the severity. Recent recommendations suggest no role for antihistamines, decongestants or antibiotics leading to various other problems like antibiotic resistance. Already established surgical management commonly involves myringotomy with grommet insertion with or without adenoidectomy and adenotonsillectomy and is now the preferred modality of treatment. This article compares the outcomes of surgical treatment with that of medical management. The aim of this study is to assess the outcomes of surgical treatment outcomes compared to the medical treatment of otitis media with effusion.
Introduction: Type 1 tympanoplasty is one of the commonest operations done by an ENT surgeon. There are a number of choices regarding the graft material that one uses in this operation. Among those, temporalis fascia and tragal perichondrium are the most common. The aim of the study was to compare the results of tympanoplasty between two groups of patients-one using temporalis fascia as the graft material and the other using tragal perichondrium. Material and methods: This prospective study group consisted of 46 patients between the ages of 10 to 49 years. Only patients with dry safe central perforations and pure conductive hearing loss were included. Success was defined as eardrum closure with no residual perforation. Hearing improvement was defined as air-bone gap less than 10dB. Results: We had included 46 patients in our study. Of them, 23 had tympanoplasty with temporalis fascia and the other 23 had tympanoplasty with tragal perichondrium. Conclusion: The study showed that both temporalis fascia and tragal perichondrium gave more or less the same results with regard to successful drum closure and hearing improvementthere was little to choose between these two.
Introduction: There are 2 types of salivary gland tumorsmajor comprising of parotid, submandibular and sublingual glands and numerous minor salivary glands with maximum number in hard palate, soft palate, buccal mucosa, nasopharynx etc. Most salivary glands tumors are benign with less than 20% of them being malignant and are named according to the cell types found under microscopy. Aims and objective of the study was to correlate the clinical diagnosis along with cytology, radiology and histopathological diagnosis and the role of FNAC, USG and CT/MRI in the neoplasms of salivary gland tumors. Material and methods: From all patients attending ENT OPD in our hospital with complaints of salivary gland swellings were evaluated according to the exclusion/inclusion criteria were selected for the study over a span of one year. FNAC is a valuable test but its role is controversial. Results: Ultrasound can delineate location, homegeneity or heterogeneity, shape, vascularity and margins. CT/MRI help in evaluating the extraglandular extension, predict possibility of malignancy based on poorly defined margins. Conclusion: In our study we found that clinical examination, FNAC and USG of the tumor gives us adequate knowledge about nature of disease and should be the ideal first line modality of investigation with CT/MRI as the next to go option for the evaluation and planning of a malignant disease management.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.